PUBLISHER: AnalystView Market Insights | PRODUCT CODE: 1252695
PUBLISHER: AnalystView Market Insights | PRODUCT CODE: 1252695
Saccharomyces Boulardii Market size was valued at USD 7,208.1 Million in 2022, expanding at a CAGR of 6.1% from 2023 to 2030.
The yeast Saccharomyces boulardii is believed to be a strain of Saccharomyces cerevisiae. It may work well for treating some types of gastroenteritis. Probiotics, or helpful microbes that assist in the fight against disease-causing bacteria, include Saccharomyces boulardii. The types of Saccharomyces cerevisiae that makeup brewer's yeast and baker's yeast are different from Saccharomyces boulardii.
Expanding blood pressure and diarrhoea-related diseases, as well as rising demand for functional foods and dietary supplements, are fueling industry growth. Since the non-pathogenic yeast Saccharomyces boulardii (Sb) has beneficial effects on the human gut, it is often recommended as a probiotic for the treatment of diarrhea and other gastrointestinal conditions. Only this yeast has been advertised for use in treating people. Diarrhea can be treated and prevented with Saccharomyces boulardii. It functions via several processes, including effects on digestive enzymes, pathogen-binding and non-toxic actions, and immunological effects.
As a potential probiotic bacterium, Saccharomyces boulardii is growing in prominence. A probiotic yeast called S. boulardii is used to address some digestive and gut issues. This probiotic yeast has shown to be very effective in preventing diarrhea brought on by enteral nutrition, severe gastroenteritis, and traveler's diarrhea. To support digestive health, it is a probiotic supplement that is used all over the globe. Different action processes and characteristics of S. boulardii can explain its effectiveness and beneficial effects on acute and chronic gastrointestinal illnesses that have been studied in clinical studies. As a consequence, there is an increase in demand for saccharomyces boulardii. Furthermore, the market's expansion is being hampered by high R&D expenses for creating new probiotic strains.
Due to rising disposable income, a boom in the demand for dietary supplements, a burgeoning technology base, and rising probiotic demand in the region, the Asia Pacific region is anticipated to have the fastest market growth during the projection period. The disposable income of livestock owners has increased significantly as a result of the quick commercial development in nations like Brazil, Argentina, China, and Japan. Asia Pacific is now the world's fastest-growing market for probiotic-based foods as a result of this increasing demand.
In September 2021, Saccharomyces boulardii Bld-3 (S. boulardii Bld-3) is a new strain of yeast probiotic that Angel Yeast Co., Ltd. ("Angel Yeast" or "Angel"), a listed high-tech yeast business in China, has created along with a cutting-edge manufacturing process for the new product. The patented yeast probiotic is intended to cure diarrhea and boost both children's and adults' healthy immune and digestive systems.
This proposed research study on the Saccharomyces Boulardii market provides market size (US$ million), compound annual growth rate (CAGR %) and forecast estimation (2023-2030), considering 2022 as the base year
The research report elucidates potential growth opportunities across different segments/countries and explains an attractive investment proposition matrix for ` the Saccharomyces Boulardii market
The overall report identifies new investment opportunities, challenges faced by established players, and growth factors to sustain the Saccharomyces Boulardii market
The impact of COVID-19 on the Saccharomyces Boulardii market size, forecast, CAGR, and market dynamics are discussed in detail under the research scope. Detailed insight into the Saccharomyces Boulardii market post-COVID will also be covered.
To give the users of this report a comprehensive view of the Saccharomyces Boulardii market, we have also included a competitive landscape and key innovator analysis for the Saccharomyces Boulardii market.
The study encompasses a growth prospect mapping analysis, wherein all the industry segments are benchmarked based on their market size, growth rate and attractiveness.
The report offers detailed company profiling featuring major market participants which will help users to understand the financial information and strategic initiatives of players operating in the Saccharomyces Boulardii market.
In addition, the report also unveils the important acquisitions & mergers, collaborations & joint ventures, new launches, research & development, and regional expansion of major participants involved in the market on global as well as regional levels.
The global Saccharomyces Boulardii market report primarily caters to various stakeholders in this industry including suppliers, investors, new entrants, distributors, and financial analysts
The scope of this report covers the market by its major segments, which include as follows:
Biocodex
Unique Biotech
SANZYME BIOLOGICS PVT. LTD.
Arla Foods, Inc.
BioGaia AB
Chr. Hansen Holding A/S
General Mills Inc.
i-Health Inc.
Lallemand Inc.
Lifeway Foods, Inc.
Mother Dairy Fruit & Vegetable Pvt. Ltd.
Nestle S.A.
Yakult Honsha Co., Ltd.
Capsules
Powders
Children
Adults
North America
The U.S.
Canada
Europe
Germany
France
Italy
Spain
United Kingdom
Russia
Netherlands
Sweden
Poland
Rest of Europe
Asia Pacific
India
China
South Korea
Japan
Australia
Thailand
Indonesia
Philippines
Rest of APAC
Latin America
Brazil
Mexico
Argentina
Colombia
Rest of LATAM
The Middle East and Africa
Saudi Arabia
United Arab Emirates
Israel
Turkey
Algeria
Egypt
Rest of MEA